Investigating medication use in older adults with late-onset rheumatoid arthritis
Official title: Understanding disease modifying antirheumatic drug use in older adults with late-onset rheumatoid arthritis
Funded at University of Michigan at Ann Arbor · NIH-10932149 · Data updated 2026-11-12
This study is looking at how older adults with late-onset rheumatoid arthritis are treated with certain medications, aiming to find out why they sometimes get less effective care and how to make their treatment better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | September 20, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $194,400 |
| NIH project number | 5K23AG082727-02 |
| Project ID | NIH-10932149 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults aged 65 and above who have been diagnosed with late-onset rheumatoid arthritis.
✕Less likely to help
Patients who are younger than 65 or those without a diagnosis of rheumatoid arthritis will not benefit from this research.
What this research studies
This research focuses on understanding how older adults with late-onset rheumatoid arthritis (LORA) are treated with disease modifying antirheumatic drugs (DMARDs). It aims to identify why these patients often receive less effective treatments and how their care can be improved. The study will involve gathering data on medication use, patient experiences, and health outcomes to develop better treatment strategies. By addressing the unique challenges faced by older adults with RA, the research seeks to enhance the overall management of this condition.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and better health outcomes for older adults suffering from rheumatoid arthritis.
How similar studies have gone: Previous research has shown that optimizing medication use in older adults with chronic conditions can lead to significant improvements in patient outcomes, indicating that this approach has potential for success.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Lee, Jiha — University of Michigan at Ann Arbor
- Study coordinator: Lee, Jiha
Related research
Other NIH-funded projects on the same topics.
-
Gut microbes and methotrexate: boosting RA treatment through microbiome targets
Researchers are studying how gut bacteria affect how well methotrexate works for people with rheumatoid arthritis, aiming to make MTX effective for more patients.
-
Hybrid biomaterial system to boost immunotherapy for rheumatoid arthritis
A new, patient-facing immunotherapy approach uses specialized particles to retrain the immune system to calm RA in adults.
-
Role of Stabilin receptors in rheumatoid arthritis
A short study to understand how certain scavenger receptors may influence the development and progression of rheumatoid arthritis in adults.
-
IgG glycosylation and endothelial FcγRIIB: understanding RA-related heart and blood vessel disease
This project looks at how rheumatoid arthritis affects blood vessels and clotting, with the goal of uncovering new ways to prevent heart and stroke risk for people with RA.
-
Risk factors and biomarkers for progression of subclinical RA-related lung disease
This study follows people with rheumatoid arthritis to understand who develops lung disease and what biomarkers predict it.
-
Pregnancy changes in rheumatoid arthritis and new treatment ideas
This research seeks to understand why some women’s rheumatoid arthritis improves during pregnancy and how to predict and mimic that effect to make treatments safer and more effective for pregnant patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.